Sagimet Biosciences Inc.(SGMT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SGMT Sagimet Biosciences Inc.

盘前交易 01-15 05:30:23 EST

6.37

+0.16

+2.58%

最高6.38	最低6.15	成交量69.81万
今开6.20	昨收6.21	日振幅3.70%
总市值2.07亿	流通市值1.44亿	总股本3,252万
成交额439.29万	换手率3.09%	流通股本2,263万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SGMT","market":"US","secType":"STK","nameCN":"Sagimet Biosciences Inc.","latestPrice":6.37,"timestamp":1768424400000,"preClose":6.21,"halted":0,"volume":698077,"delay":0,"floatShares":22626486,"shares":32521599,"eps":-1.786134,"marketStatus":"盘前交易","change":0.16,"latestTime":"01-15 05:30:23 EST","open":6.2,"high":6.38,"low":6.15,"amount":4392939.4338781,"amplitude":0.037037,"askPrice":7.12,"askSize":100,"bidPrice":6.15,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.786134,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768487400000},"marketStatusCode":1,"adr":0,"listingDate":1689307200000,"exchange":"NASDAQ","adjPreClose":6.37,"postHourTrading":{"tag":"盘后","latestPrice":6.3586,"preClose":6.37,"latestTime":"19:49 EST","volume":2519,"amount":16033.484,"timestamp":1768438168267},"volumeRatio":0.8138916682396024,"impliedVol":1.1687,"impliedVolPercentile":0.252},"requestUrl":"/m/hq/s/SGMT","defaultTab":"news","newsList":[{"id":"2593144756","title":"Sagimet Biosciences Inc. - Series A盘中异动 临近收盘快速拉升5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593144756","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593144756?lang=zh_cn&edition=full","pubTime":"2025-12-20 04:37","pubTimestamp":1766176679,"startTime":"0","endTime":"0","summary":"北京时间2025年12月20日04时37分，Sagimet Biosciences Inc. - Series A股票出现异动，股价快速拉升5.03%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为1.28%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂，旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251220043759a4615953&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251220043759a4615953&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"1141511236","title":"Sagimet Biosciences发布Denifanstat和Resmetirom联合用药的一期PK临床试验积极结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1141511236","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141511236?lang=zh_cn&edition=full","pubTime":"2025-12-18 20:01","pubTimestamp":1766059299,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences发布Denifanstat和Resmetirom联合用药的一期PK临床试验积极结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"1159376043","title":"Sagimet Biosciences - Denifanstat与Resmetirom的联合试验正在进行中，预计2025年底将公布初步数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1159376043","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159376043?lang=zh_cn&edition=full","pubTime":"2025-12-17 20:09","pubTimestamp":1765973372,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences - Denifanstat与Resmetirom的联合试验正在进行中，预计2025年底将公布初步数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2588063982","title":"Sagimet Biosciences Inc. - Series A盘中异动 急速跳水5.00%报6.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588063982","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588063982?lang=zh_cn&edition=full","pubTime":"2025-12-03 01:51","pubTimestamp":1764697913,"startTime":"0","endTime":"0","summary":"北京时间2025年12月03日01时51分，Sagimet Biosciences Inc. - Series A股票出现异动，股价大幅下跌5.00%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.38%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂，旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203015154a4c88b9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203015154a4c88b9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"2585274165","title":"Sagimet Biosciences Inc. - Series A盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585274165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585274165?lang=zh_cn&edition=full","pubTime":"2025-11-21 04:02","pubTimestamp":1763668977,"startTime":"0","endTime":"0","summary":"北京时间2025年11月21日04时02分，Sagimet Biosciences Inc. - Series A股票出现波动，股价急速跳水5.08%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.50%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂，旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121040257a4afe246&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121040257a4afe246&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2582337832","title":"Sagimet Biosciences Inc. - Series A盘中异动 股价大涨5.25%报7.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582337832","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582337832?lang=zh_cn&edition=full","pubTime":"2025-11-10 22:39","pubTimestamp":1762785593,"startTime":"0","endTime":"0","summary":"北京时间2025年11月10日22时39分，Sagimet Biosciences Inc. - Series A股票出现波动，股价快速拉升5.25%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.67%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂，旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110223953a6efc1fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110223953a6efc1fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"2574168754","title":"Sagimet Biosciences Inc. - Series A盘中异动 早盘快速拉升6.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574168754","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574168754?lang=zh_cn&edition=full","pubTime":"2025-10-09 21:31","pubTimestamp":1760016709,"startTime":"0","endTime":"0","summary":"北京时间2025年10月09日21时31分，Sagimet Biosciences Inc. - Series A股票出现波动，股价快速拉升6.02%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体跌幅为0.13%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂，旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251009213149a4585ffe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251009213149a4585ffe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"1162093241","title":"Sagimet Biosciences宣布Denifanstat和Resmetirom联合用药1期药代动力学临床试验首批参与者开始给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1162093241","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162093241?lang=zh_cn&edition=full","pubTime":"2025-10-01 19:02","pubTimestamp":1759316572,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences公司宣布，其Denifanstat和Resmetirom联合用药的1期药代动力学临床试验已开始对首批参与者进行给药。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2569167707","title":"Sagimet Biosciences Inc. - Series A盘中异动 急速上涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2569167707","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569167707?lang=zh_cn&edition=full","pubTime":"2025-09-22 23:29","pubTimestamp":1758554955,"startTime":"0","endTime":"0","summary":"北京时间2025年09月22日23时29分，Sagimet Biosciences Inc. - Series A股票出现异动，股价大幅拉升5.06%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.77%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂，旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092223291697a2b1d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092223291697a2b1d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"1196381432","title":"合作伙伴Ascletis将在2025年EADV大会上展示Denifanstat治疗中重度痤疮的积极三期临床结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1196381432","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196381432?lang=zh_cn&edition=full","pubTime":"2025-09-17 19:01","pubTimestamp":1758106899,"startTime":"0","endTime":"0","summary":"合作伙伴Ascletis将在2025年EADV大会上展示Denifanstat治疗中重度痤疮的积极三期临床结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"2562729399","title":"Sagimet Biosciences Inc. - Series A盘中异动 快速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562729399","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562729399?lang=zh_cn&edition=full","pubTime":"2025-08-27 23:23","pubTimestamp":1756308226,"startTime":"0","endTime":"0","summary":"北京时间2025年08月27日23时23分，Sagimet Biosciences Inc. - Series A股票出现波动，股价大幅拉升5.00%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.16%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂，旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508272323479500c558&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508272323479500c558&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4561","MT","BK4139","BK4006","SGMT"],"gpt_icon":0},{"id":"2558866487","title":"Sagimet Biosciences Inc. - Series A盘中异动 急速拉升5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558866487","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558866487?lang=zh_cn&edition=full","pubTime":"2025-08-11 23:55","pubTimestamp":1754927754,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日23时55分，Sagimet Biosciences Inc. - Series A股票出现异动，股价快速上涨5.38%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.26%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂，旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081123555494dcf5d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081123555494dcf5d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"2557393033","title":"Sagimet Biosciences Inc. - Series A盘中异动 临近收盘大幅拉升5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557393033","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557393033?lang=zh_cn&edition=full","pubTime":"2025-08-05 03:43","pubTimestamp":1754336586,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日03时43分，Sagimet Biosciences Inc. - Series A股票出现波动，股价急速拉升5.33%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为1.61%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂，旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080503430694cf85c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080503430694cf85c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2556817829","title":"Sagimet Biosciences Inc. - Series A盘中异动 早盘急速跳水5.06%报8.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556817829","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556817829?lang=zh_cn&edition=full","pubTime":"2025-08-01 23:01","pubTimestamp":1754060505,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日23时01分，Sagimet Biosciences Inc. - Series A股票出现异动，股价急速下跌5.06%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体跌幅为0.11%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂，旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801230146a470035b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801230146a470035b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"2555902961","title":"Sagimet Biosciences Inc. - Series A盘中异动 下午盘急速下跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555902961","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555902961?lang=zh_cn&edition=full","pubTime":"2025-07-31 02:57","pubTimestamp":1753901841,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日02时57分，Sagimet Biosciences Inc. - Series A股票出现异动，股价快速下挫5.07%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.35%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂，旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073102572297285ed3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073102572297285ed3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2555050244","title":"Sagimet Biosciences Inc. - Series A盘中异动 早盘股价大跌5.13%报9.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555050244","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555050244?lang=zh_cn&edition=full","pubTime":"2025-07-29 22:52","pubTimestamp":1753800726,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日22时52分，Sagimet Biosciences Inc. - Series A股票出现异动，股价急速跳水5.13%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.42%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂，旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729225206a469e393&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729225206a469e393&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2554777721","title":"Sagimet Biosciences Inc. - Series A盘中异动 早盘快速下跌5.57%报9.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554777721","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554777721?lang=zh_cn&edition=full","pubTime":"2025-07-28 22:19","pubTimestamp":1753712367,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日22时19分，Sagimet Biosciences Inc. - Series A股票出现波动，股价快速跳水5.57%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.20%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂，旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728221927a6c625e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728221927a6c625e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2518716122","title":"Sagimet Biosciences Inc. - Series A盘中异动 早盘股价大跌5.03%报3.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518716122","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518716122?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:36","pubTimestamp":1741617379,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时36分，Sagimet Biosciences Inc. - Series A股票出现异动，股价快速下挫5.03%。截至发稿，该股报3.50美元/股，成交量12.7763万股，换手率0.40%，振幅6.39%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.02%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022362096404608&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022362096404608&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"2516668736","title":"Sagimet Biosciences Inc. - Series A盘中异动 下午盘股价大跌5.25%报3.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516668736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516668736?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:14","pubTimestamp":1741032869,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时14分，Sagimet Biosciences Inc. - Series A股票出现波动，股价大幅下跌5.25%。截至发稿，该股报3.52美元/股，成交量36.6198万股，换手率1.14%，振幅6.94%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.04%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304041429989a5bfc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304041429989a5bfc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2514041389","title":"Sagimet Biosciences Inc. - Series A盘中异动 早盘股价大涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514041389","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514041389?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:15","pubTimestamp":1740669353,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时15分，Sagimet Biosciences Inc. - Series A股票出现波动，股价快速拉升5.21%。截至发稿，该股报4.04美元/股，成交量8.3992万股，换手率0.26%，振幅3.69%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.99%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227231553989519d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227231553989519d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SGMT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sagimet.com","stockEarnings":[{"period":"1week","weight":0.154},{"period":"1month","weight":0.0564},{"period":"3month","weight":-0.1563},{"period":"6month","weight":-0.3231},{"period":"1year","weight":0.5331},{"period":"ytd","weight":0.076}],"compareEarnings":[{"period":"1week","weight":0.0011},{"period":"1month","weight":0.0141},{"period":"3month","weight":0.045},{"period":"6month","weight":0.1},{"period":"1year","weight":0.1858},{"period":"ytd","weight":0.0124}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Sagimet Biosciences Inc.于2006年12月19日在特拉华州注册成立，名称为3-V Biosciences，Inc.，总部位于加利福尼亚州圣马特奥。该公司于2019年8月将其名称从3-V Biosciences，Inc.更改为Sagimet Biosciences Inc.。该公司是临床阶段的生物制药公司，致力于开发内部发现的选择性脂肪酸合酶抑制剂组合，用于治疗因脂质代谢功能障碍而导致的疾病。","exchange":"NASDAQ","name":"Sagimet Biosciences Inc.","nameEN":"Sagimet Biosciences Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Sagimet Biosciences Inc.(SGMT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Sagimet Biosciences Inc.(SGMT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Sagimet Biosciences Inc.,SGMT,Sagimet Biosciences Inc.股票,Sagimet Biosciences Inc.股票老虎,Sagimet Biosciences Inc.股票老虎国际,Sagimet Biosciences Inc.行情,Sagimet Biosciences Inc.股票行情,Sagimet Biosciences Inc.股价,Sagimet Biosciences Inc.股市,Sagimet Biosciences Inc.股票价格,Sagimet Biosciences Inc.股票交易,Sagimet Biosciences Inc.股票购买,Sagimet Biosciences Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Sagimet Biosciences Inc.(SGMT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Sagimet Biosciences Inc.(SGMT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}